These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1700488

  • 21. [Effect of streptokinase on the interaction of alpha-2-antiplasmin with different sites of plasmin molecule].
    Iusova EI, Grinenko TV, Volkov GL.
    Ukr Biokhim Zh (1999); 2004; 76(2):98-106. PubMed ID: 15915719
    [Abstract] [Full Text] [Related]

  • 22. Interaction of SK-human plasmin, SK-dog plasmin complexes with alpha 2-antiplasmin and alpha 2-macroglobulin.
    Reddy KN, Cercek B, Lew AS, Ganz W.
    Thromb Res; 1986 Mar 01; 41(5):671-80. PubMed ID: 2421434
    [Abstract] [Full Text] [Related]

  • 23. Identification of divalent metal ion-dependent inhibition of activated protein C by alpha 2-macroglobulin and alpha 2-antiplasmin in blood and comparisons to inhibition of factor Xa, thrombin, and plasmin.
    Heeb MJ, Gruber A, Griffin JH.
    J Biol Chem; 1991 Sep 15; 266(26):17606-12. PubMed ID: 1716632
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of plasmin generation in plasma by heparin, low molecular weight heparin, and a covalent antithrombin-heparin complex.
    Chang GMT, Atkinson HM, Berry LR, Chan AKC.
    Blood Coagul Fibrinolysis; 2017 Sep 15; 28(6):431-437. PubMed ID: 27898513
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Kinetic analysis of the heparin-enhanced plasmin--antithrombin III reaction. Apparent catalytic role of heparin.
    Machovich R, Bauer PI, Arányi P, Kecskés E, Büki KG, Horváth I.
    Biochem J; 1981 Dec 01; 199(3):521-6. PubMed ID: 6462134
    [Abstract] [Full Text] [Related]

  • 27. Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin.
    Leebeek FW, Kluft C, Knot EA, Los P, Cohen AF, Six AJ.
    J Am Coll Cardiol; 1990 May 01; 15(6):1212-20. PubMed ID: 1691750
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Association of alpha 2-macroglobulin-thrombin and alpha 2-macroglobulin-plasmin complexes with isolated hepatocytes.
    Spolarics Z, Mandl J, Machovich R, Lambin P, Garzó T, Antoni F, Horváth I.
    Biochim Biophys Acta; 1985 Jun 30; 845(3):389-95. PubMed ID: 2408676
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The regulation of human factor XIIa by plasma proteinase inhibitors.
    Pixley RA, Schapira M, Colman RW.
    J Biol Chem; 1985 Feb 10; 260(3):1723-9. PubMed ID: 2578463
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Is the imbalance between thrombin and plasmin activity in diabetes related to the behaviour of antiplasmin activity?
    Marongiu F, Conti M, Mameli G, Sorano GG, Cossu E, Cirillo R, Balestrieri A.
    Thromb Res; 1990 Apr 15; 58(2):91-9. PubMed ID: 1693451
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Kinetics of plasmin inhibition in the presence of a synthetic tripeptide substrate. The reaction with pancreatic trypsin inhibitor and two forms of alpha 2-plasmin inhibitor.
    Petersen LC, Clemmensen I.
    Biochem J; 1981 Oct 01; 199(1):121-7. PubMed ID: 6175313
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.